May 2003
Volume 44, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2003
Role of c-MYC Protein in Platelet-Derived Growth Factor (PDGF)-Induced Mitogenesis of Human Retinal Pigment Epithelial (hRPE) Cells
Author Affiliations & Notes
  • J.D. Paauw
    Ophthalmology, University Michigan, Ann Arbor, MI, United States
  • P.C. Kothary
    Ophthalmology, University Michigan, Ann Arbor, MI, United States
  • M.A. Del Monte
    Ophthalmology, University Michigan, Ann Arbor, MI, United States
  • Footnotes
    Commercial Relationships  J.D. Paauw, None; P.C. Kothary, None; M.A. Del Monte, None.
  • Footnotes
    Support  Skillman Foundation, RPB Foundation
Investigative Ophthalmology & Visual Science May 2003, Vol.44, 2945. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      J.D. Paauw, P.C. Kothary, M.A. Del Monte; Role of c-MYC Protein in Platelet-Derived Growth Factor (PDGF)-Induced Mitogenesis of Human Retinal Pigment Epithelial (hRPE) Cells . Invest. Ophthalmol. Vis. Sci. 2003;44(13):2945.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: PDGF is a growth factor for human retinal pigment epithelial (hRPE) cells and has been implicated in pathological epiretinal membrane formation. We investigated the roles of the intracellular signaling molecule Stat3 and protooncogene c-Myc in PDGF-induced hRPE cell proliferation. Methods: hRPE cultures were established from three human eyes obtained from the Michigan Eye Bank. Proliferation of hRPE cells in the presence of increasing concentrations of PDGF (1-100 pg/ml), and in the presence and absence of AG490, a Jak/STAT signaling inhibitor, and Genistein, a phosphotyrosine kinase pathway inhibitor, was measured by direct counting of trypan blue excluding cells. c-Myc protein synthesis was measured by immunoprecipitating 14C-Methionine-labeled c-Myc in the presence of increasing concentrations of PDGF (1-100 pg/ml), and in the presence and absence of AG490 and genistein. Data were analyzed by Student 't' test. p<0.05 was considered to be significantly different. Results: PDGF stimulated hRPE proliferation in a dose-dependent manner. Genistein (0.025 mM) inhibited PDGF (100 pg/ml) stimulated hRPE proliferation (6.5 ±4.1 vs. 21.3 ±7.2, cell number x105± SEM, p=0.0003, n=5). AG490 (0.025mM) also inhibited PDGF (100 pg/ml) stimulated hRPE cell number (1.5 ±1.1 vs. 21.3 ±7.2, cell number x 105± SEM, p=0.0006, n=5). PDGF stimulated c-Myc synthesis in a dose dependent manner. Genistein (0.025 mM) inhibited PDGF (100 pg/ml) stimulated c-Myc synthesis (393.3 ±89.8 vs. 1082.8± 246.1, CPM±SEM, p=0.013, n=6). AG490 (0.025 mM) inhibited PDGF (100 pg/ml) stimulated c-Myc synthesis (279.7 ±114.3 vs. 1082.8± 246.1, CPM±SEM, p=0.019, n=6). Conclusions: PDGF stimulates hRPE cell proliferation through a phosphorylation cascade involving STAT activation and c-Myc synthesis. AG490 or genistein may be useful in preventing or treating proliferative eye diseases.

Keywords: retinal pigment epithelium • growth factors/growth factor receptors • signal transduction 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×